Haven Private, LLC: BCO position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Haven Private, LLC on BCO, newest first. How the timeline and the estimate are built.
Haven Private, LLC held 3,752 BCO shares at 2026-06-30 per its 13F-HR filed 2026-07-29.
the latest 13F is the newest step
- period ended2026-06-3013F 3,752 sharesChange vs previous 13F -1,610 shares
0.13% of the 13F portfolio, value $354,526.
13F-HR 0001705819-26-000047 filed by Haven Private, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 5,362 sharesChange vs previous 13F +89 shares
0.24% of the 13F portfolio, value $555,664.
13F-HR 0001705819-26-000033 filed by Haven Private, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 5,273 sharesChange vs previous 13F +625 shares
0.27% of the 13F portfolio, value $615,517.
13F-HR 0001705819-26-000021 filed by Haven Private, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 4,648 sharesChange vs previous 13F +973 shares
0.24% of the 13F portfolio, value $543,165.
13F-HR 0001705819-25-000080 filed by Haven Private, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 3,675 sharesChange vs previous 13F +1,231 shares
0.15% of the 13F portfolio, value $328,141.
13F-HR 0001705819-25-000053 filed by Haven Private, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 2,444 sharesChange vs previous 13F not available
0.12% of the 13F portfolio, value $210,575.
13F-HR 0001705819-25-000035 filed by Haven Private, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).